Business News By Deena Beasley SAN DIEGO (Reuters) - Allergan - TopicsExpress



          

Business News By Deena Beasley SAN DIEGO (Reuters) - Allergan Inc , seeking to win over shareholders as it fights a hostile takeover offer from Valeant Pharmaceuticals International Inc , will raise its earnings outlook when it reports second-quarter results, said Chief Executive Officer David Pyott. The CEO and Allergans board earlier on Monday encouraged investors not to sell their shares to Valeant, calling the Canada-based companys offer grossly inadequate. Pyott, speaking on the sidelines of the annual BIO International Convention, said shareholders are vocal in asking that the California-based Botox maker boost earnings and deploy capital - in the form of share buybacks or a significant acquisition. In May, Allergan said it expected full-year 2014 earnings of between $5.64 and $5.73 per share.
Posted on: Tue, 24 Jun 2014 04:18:13 +0000

Trending Topics



Recently Viewed Topics




© 2015